WO2011113925A2 - Carbonylation de composés organiques de zinc - Google Patents
Carbonylation de composés organiques de zinc Download PDFInfo
- Publication number
- WO2011113925A2 WO2011113925A2 PCT/EP2011/054104 EP2011054104W WO2011113925A2 WO 2011113925 A2 WO2011113925 A2 WO 2011113925A2 EP 2011054104 W EP2011054104 W EP 2011054104W WO 2011113925 A2 WO2011113925 A2 WO 2011113925A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- compounds
- formula
- licl
- organic
- Prior art date
Links
- 150000003752 zinc compounds Chemical class 0.000 title description 8
- 230000006315 carbonylation Effects 0.000 title description 2
- 238000005810 carbonylation reaction Methods 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 67
- 150000001735 carboxylic acids Chemical class 0.000 claims abstract description 27
- 150000002576 ketones Chemical class 0.000 claims abstract description 12
- 125000000524 functional group Chemical group 0.000 claims abstract description 11
- 238000004519 manufacturing process Methods 0.000 claims abstract description 11
- 150000001298 alcohols Chemical class 0.000 claims abstract description 10
- 150000001412 amines Chemical class 0.000 claims abstract description 9
- 150000001408 amides Chemical class 0.000 claims abstract description 7
- 150000002148 esters Chemical class 0.000 claims abstract description 7
- 150000001299 aldehydes Chemical class 0.000 claims abstract description 6
- 150000002894 organic compounds Chemical class 0.000 claims abstract description 6
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 claims description 72
- 238000006243 chemical reaction Methods 0.000 claims description 40
- 238000000034 method Methods 0.000 claims description 36
- -1 alkyl radicals Chemical class 0.000 claims description 31
- 238000002360 preparation method Methods 0.000 claims description 30
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims description 18
- 125000003118 aryl group Chemical group 0.000 claims description 18
- 229960001680 ibuprofen Drugs 0.000 claims description 17
- 230000008569 process Effects 0.000 claims description 17
- 125000000217 alkyl group Chemical group 0.000 claims description 14
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 12
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 12
- 239000011777 magnesium Substances 0.000 claims description 12
- 150000003254 radicals Chemical class 0.000 claims description 12
- 125000001072 heteroaryl group Chemical group 0.000 claims description 10
- 229910052749 magnesium Inorganic materials 0.000 claims description 10
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 9
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 claims description 8
- 150000004820 halides Chemical group 0.000 claims description 7
- 125000001424 substituent group Chemical group 0.000 claims description 7
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 6
- 239000001569 carbon dioxide Substances 0.000 claims description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- 150000002466 imines Chemical class 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 150000001728 carbonyl compounds Chemical class 0.000 claims description 3
- 239000012948 isocyanate Substances 0.000 claims description 3
- 150000002513 isocyanates Chemical class 0.000 claims description 3
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 claims description 2
- 229960003184 carprofen Drugs 0.000 claims description 2
- IVUMCTKHWDRRMH-UHFFFAOYSA-N carprofen Chemical compound C1=CC(Cl)=C[C]2C3=CC=C(C(C(O)=O)C)C=C3N=C21 IVUMCTKHWDRRMH-UHFFFAOYSA-N 0.000 claims description 2
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 claims description 2
- 229960002390 flurbiprofen Drugs 0.000 claims description 2
- 229960002009 naproxen Drugs 0.000 claims description 2
- CMWTZPSULFXXJA-VIFPVBQESA-M naproxen(1-) Chemical compound C1=C([C@H](C)C([O-])=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-M 0.000 claims description 2
- 229960003424 phenylacetic acid Drugs 0.000 claims description 2
- 239000003279 phenylacetic acid Substances 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 description 37
- 239000011701 zinc Substances 0.000 description 36
- 239000003153 chemical reaction reagent Substances 0.000 description 35
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 32
- 230000009257 reactivity Effects 0.000 description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 238000003786 synthesis reaction Methods 0.000 description 11
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- 125000001743 benzylic group Chemical group 0.000 description 9
- 229910052794 bromium Inorganic materials 0.000 description 8
- 229910052801 chlorine Inorganic materials 0.000 description 8
- 229910052740 iodine Inorganic materials 0.000 description 8
- 238000007792 addition Methods 0.000 description 7
- 238000005580 one pot reaction Methods 0.000 description 7
- KEAGRYYGYWZVPC-UHFFFAOYSA-N 1-[4-(2-methylpropyl)phenyl]ethanone Chemical compound CC(C)CC1=CC=C(C(C)=O)C=C1 KEAGRYYGYWZVPC-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000003780 insertion Methods 0.000 description 6
- 230000037431 insertion Effects 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 231100000331 toxic Toxicity 0.000 description 6
- 230000002588 toxic effect Effects 0.000 description 6
- SPBVCQUMYJRBMD-UHFFFAOYSA-N 1-(1-chloroethyl)-4-(2-methylpropyl)benzene Chemical compound CC(C)CC1=CC=C(C(C)Cl)C=C1 SPBVCQUMYJRBMD-UHFFFAOYSA-N 0.000 description 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 241000894007 species Species 0.000 description 5
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- 229910052723 transition metal Inorganic materials 0.000 description 4
- 150000003624 transition metals Chemical class 0.000 description 4
- RPTRFSADOICSSK-UHFFFAOYSA-N 2-(2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC=C1F RPTRFSADOICSSK-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 239000002841 Lewis acid Substances 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000007259 addition reaction Methods 0.000 description 3
- BIPUHAHGLJKIPK-UHFFFAOYSA-N dicyclopropylmethanone Chemical compound C1CC1C(=O)C1CC1 BIPUHAHGLJKIPK-UHFFFAOYSA-N 0.000 description 3
- 239000012039 electrophile Substances 0.000 description 3
- 150000007517 lewis acids Chemical class 0.000 description 3
- 150000002902 organometallic compounds Chemical class 0.000 description 3
- QJPJQTDYNZXKQF-UHFFFAOYSA-N 4-bromoanisole Chemical compound COC1=CC=C(Br)C=C1 QJPJQTDYNZXKQF-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 2
- DCERHCFNWRGHLK-UHFFFAOYSA-N C[Si](C)C Chemical compound C[Si](C)C DCERHCFNWRGHLK-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 150000001499 aryl bromides Chemical class 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 238000006263 metalation reaction Methods 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- 238000006464 oxidative addition reaction Methods 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- VOLGAXAGEUPBDM-UHFFFAOYSA-N $l^{1}-oxidanylethane Chemical compound CC[O] VOLGAXAGEUPBDM-UHFFFAOYSA-N 0.000 description 1
- MGKPFALCNDRSQD-UHFFFAOYSA-N 2-(4-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=C(F)C=C1 MGKPFALCNDRSQD-UHFFFAOYSA-N 0.000 description 1
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical compound [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 description 1
- WZWIQYMTQZCSKI-UHFFFAOYSA-N 4-cyanobenzaldehyde Chemical compound O=CC1=CC=C(C#N)C=C1 WZWIQYMTQZCSKI-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229910007424 ZnC Inorganic materials 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 150000001503 aryl iodides Chemical class 0.000 description 1
- 150000003935 benzaldehydes Chemical class 0.000 description 1
- 150000001649 bromium compounds Chemical group 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- LIQBAAKGMWRWPS-UHFFFAOYSA-M chlorozinc(1+);methanidylbenzene Chemical compound [Zn+]Cl.[CH2-]C1=CC=CC=C1 LIQBAAKGMWRWPS-UHFFFAOYSA-M 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- QILSFLSDHQAZET-UHFFFAOYSA-N diphenylmethanol Chemical compound C=1C=CC=CC=1C(O)C1=CC=CC=C1 QILSFLSDHQAZET-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 150000003949 imides Chemical group 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 150000002681 magnesium compounds Chemical class 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002896 organic halogen compounds Chemical class 0.000 description 1
- 150000002901 organomagnesium compounds Chemical class 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000006478 transmetalation reaction Methods 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- B01J31/12—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing organo-metallic compounds or metal hydrides
- B01J31/122—Metal aryl or alkyl compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B49/00—Grignard reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
- C07C41/30—Preparation of ethers by reactions not forming ether-oxygen bonds by increasing the number of carbon atoms, e.g. by oligomerisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/15—Preparation of carboxylic acids or their salts, halides or anhydrides by reaction of organic compounds with carbon dioxide, e.g. Kolbe-Schmitt synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F3/06—Zinc compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/30—Addition reactions at carbon centres, i.e. to either C-C or C-X multiple bonds
- B01J2231/32—Addition reactions to C=C or C-C triple bonds
- B01J2231/321—Hydroformylation, metalformylation, carbonylation or hydroaminomethylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
Definitions
- the invention relates to processes for the preparation of organic compounds having at least one functional group, in particular of carboxylic acids, alcohols, esters, amides, ketones, aldehydes or amines, as well as compounds for their preparation and uses and the preparation of such compounds.
- functional group in particular of carboxylic acids, alcohols, esters, amides, ketones, aldehydes or amines
- Organometallic compounds are characterized by their high tolerance to functional groups and would therefore be ideally suited as nucleophiles for addition reactions to carbonyl groups.
- organozinc compounds are normally inert to addition to carbonyl groups and provide only low yields. It is known that Lewis acids, such as CeCl 3 or LaCl 3 -2LiCl, must be used to increase the reactivity of carbonyl groups towards nucleophilic attack (Krasovskiy, 2006).
- Organic carboxylic acids are of high economic importance, for example in the pharmaceutical field.
- Examples of economically important carboxylic acids are Ibuprofen and phenylacetic acid derivatives (Martinez, 1993).
- the known synthetic routes are often complicated and complicated or require toxic or expensive reagents.
- the invention has for its object to provide methods and compounds which overcome the disadvantages mentioned above.
- the invention is in particular the object of providing an efficient process for the production of organic carboxylic acids. It should be available in a simple manner and in an efficient process a variety of different organic carboxylic acids.
- the method should preferably be feasible without toxic, aggressive or expensive reagents or catalysts. In particular, the use of precious metals should be avoided.
- the method should also be energy efficient at low temperature and in a few steps within a short time feasible.
- the invention addresses the problem of providing an efficient method for the synthesis of ibuprofen or similar organic carboxylic acids of pharmaceutical interest.
- the invention is also based on the object to provide reagents which are suitable for the production of organic carboxylic acids. Furthermore, new efficient processes for the preparation of organic compounds having at least one functional group, in particular of carboxylic acids, alcohols, esters, amides, ketones, aldehydes or amines, as well as compounds for their preparation are to be provided.
- the invention relates to a process for the preparation of organic carboxylic acids, comprising the steps a) providing a compound of the formula (Ia) or (Ib):
- R, R 1 and R 2 are organic radicals which are selected independently of one another from benzyl, aryl, heteroaryl and alkyl radicals.
- R 1 and R 2 are preferably identical, but they may also be different in a compound (Ib).
- the halide X is preferably I, Br or Cl.
- the halide Cl is preferably, in particular when using benzylic zinc reagents.
- the zinc is bonded to carbon atoms.
- the compounds are thus organometallischer nature.
- the zinc in the compounds (Ia) and (Ib) is not bonded directly to a heteroaryl radical.
- R, R 1 and R 2 are benzyl radicals wherein the aromatic ring of the benzyl radical is optionally substituted with at least one substituent R 4 selected as indicated below.
- the length of the alkyl group is preferably between 1 and 10 carbon atoms, more preferably methyl, ethyl or propyl.
- the alkoxy radical is preferably a methoxy or ethoxy radical.
- the compound of the formula (Ia) or (Ib) is initially prepared in a step aO), starting from a compound of the formula (III):
- R-X (III) by a reaction with magnesium, LiCl and ZnC .
- the compound R-X is a bromide, in particular an aryl bromide. These are generally cheaper and better available than the comparable iodides.
- the zinc compounds used in the present process are prepared by direct insertion of magnesium metal into organic halogen compounds in the presence of ZnCl 2 and LiCl (exemplified in Scheme 1).
- ZnCl 2 is prepared by direct insertion of magnesium metal into organic halogen compounds in the presence of ZnCl 2 and LiCl (exemplified in Scheme 1).
- R aryl, benzyl, alk
- Scheme 1 Exemplary preparation of organozinc compounds by direct magnesium insertion in the presence of ZnCl 2 and LiCl.
- R may also have other meanings, for example heteroaryl.
- the preparation of the compounds (Ia) and (Ib) takes place in a one-pot process.
- one-pot processes are generally advantageous since expensive purification steps are eliminated and comparatively simple devices can be used.
- the further conversion to organic carboxylic acids or other organic compounds takes place.
- organozinc compounds of the composition RZnX-LiCl with MgCl 2 powder or a solution of MgCl 2 in THF (Scheme 2, Equation 1).
- the advantage of the one-pot process lies in the significantly shorter reaction times and lower temperatures required for the preparation and in the possibility of displaying diorganozinc species.
- the preparation of aromatic zinc compounds by the in situ methodology is also possible starting from aryl bromides. It is also possible to react Grignard compounds of the type RMgX-LiCl with ⁇ 2 solution to give compounds of the type Ia and Ib (Scheme 2, Equation 2).
- there is a restriction here with respect to the functional groups since it is assumed that an organomagnesium compound is used.
- R aryl, benzyl, alkyl
- R aryl, alkyl
- X Cl, Br, I Scheme 2: Further Exemplary Representation of Zinc Compounds of Composition Ia and Ib.
- R can also have other meanings, for example heteroaryl or benzyl.
- the one-pot process resulting from the transmetalation reaction also MgCl 2 coordinates in the form of complex aggregates of the composition RZnX-MgCl 2 -LiCl or R ⁇ Zn-MgC ⁇ -LiCl in spatial proximity to the zinc atom.
- This coordination sphere then allows the addition of C0 2 (Scheme 2a), carbonyl compounds, and imines under Lewis acid activation, probably via six-membered transition states.
- Scheme 2a Lewis acid-mediated addition of organozinc reagents to CO 2 .
- R aryl, benzyl, alkyl
- X Cl, Br, I Scheme 3: Exemplary addition of organozinc compounds to CO 2 - representation of carboxylic acids. R can also have other meanings, for example heteroaryl.
- the invention also provides a compound of the formula (Ib):
- R 1 and R 2 are organic radicals and X is a halide.
- the radicals R 1 , R 2 and X are preferably selected as indicated above.
- the invention also provides a process for preparing a compound of the formula (Ib), where a compound of the formula (III):
- R benzyl, aryl, heteroaryl, alkyl
- FG OMe, CF 3, Hai, C0 2 Et, CN, SMe, HNBoc, TMS, NR 2, OTIPS
- the compounds of the formula (Ib) have good stability.
- the organozinc species were usually prepared on a 20 mmol scale and then consumed within a period of 2-3 weeks. During this period, no significant change in concentration could be detected by titration with iodine.
- the compounds of formula (Ib) according to the invention may generally be used for the preparation of organic compounds having functional groups such as carboxylic acids, esters, ketones, imides, alcohols, amides or amines, e.g. be used with the use of carbon dioxide, carbonyl compounds, isocyanates or imines.
- ketones or aldehydes can be used as starting materials for the preparation of alcohols.
- the reaction with imines allows the preparation of amines.
- the reaction with isocyanates allows the preparation of amides.
- the further esterification or amidation of the products allows the synthesis of esters and amides.
- the starting materials used are compounds R-X as described above. The procedure can be analogous to the procedures of Metzger, 2008 and Piller, 2008.
- reactions with further starting compounds, such as nitriles, epoxides, thioesters, etc. are also conceivable.
- the compound (Ia) is 1- (4'-isobutylphenyl) ethyl-Zn-Cl-MgCl 2 -LiCl and the compound (II) is ibuprofen.
- Ibuprofen is an important medicine that has anti-inflammatory, analgesic and anti-pyretic effects.
- the synthesis relies entirely on the use of toxic and costly reagents and also does not use environmentally questionable transition metal based catalyst systems such as palladium catalysts.
- this newly developed ibuprofen synthesis offers a more cost-efficient and ecologically safer access to ibuprofen (8) in a very high yield (Scheme 5).
- ibuprofen The synthesis of ibuprofen is based on the commercially available 4-isobutylacetophenone
- the process according to the invention is used for the preparation of phenylacetic acid derivatives.
- the starting compound of the formula (III) is then a compound aryl / heteroaryl-CH 2 -X or a derivative thereof.
- the reaction of benzylic zinc compounds of the formula (Ia) or (Ib) with C0 2 allows the preparation of phenylacetic acid derivatives of type 9, which are common target molecules of pharmaceutical chemistry.
- Scheme 6 Exemplary general representation of type 9 phenylacetic acid derivatives.
- the inventive method for producing a variety of organic acids can be used.
- the process is used for the preparation of ibuprofen, naproxen, fluribiprofen, carprofen, phenylacetic acid or derivatives of these acids.
- the process of the present invention application with the zinc reagents used differs markedly from organozinc species that result from metallation reactions with the zinc amide base (tmp) 2 Zn-2MgCl 2 -2LiCl. Since it is only possible with the help of Zinka- midbase to metallate electron-deficient aromatic or heteroaromatic systems, only aromatic zinc reagents with highly electron-withdrawing functional groups or very electron-poor heterocyclic zinc reagents can be obtained in this way. However, due to their electronic properties, these zinc species are not reactive enough to react with the electrophile CO 2 . Consequently, even in these substrate classes, the metallation method does not represent an alternative to the oxidative additions used here for the preparation of the zinc reagents.
- carboxylic acids were synthesized according to the method of the present invention with CO2.
- Table 1 shows the reactions. Indicated are also the reaction times and yields.
- MeO MeO "MeO kZn-2MgBrCl-2LiCl 12/50 ° C C0 2 H 76
- the innovation and the advantage of the invention on the one hand is that the reactions can be carried out under relatively mild conditions without transition metal catalysis in the toxicologically acceptable solvent THF. Furthermore, it was shown that functionalized benzylic zinc reagents of the composition RZnCl LiCl (R: benzyl), which had been prepared by zinc insertion in the presence of LiCl, showed no reactivity towards CO 2 in THF.
- LiCl (1.06 g, 25.0 mmol) was dried in a Schlenk tube for 10 min at 500 ° C under high vacuum and then dissolved under argon in THF (10 ml).
- ZnCl 2 (11.0 mL, 11.0 mmol, 1.00 M in THF) and magnesium turnings (0.61 g, 25.0 mmol) were added and the reaction mixture was cooled to 25 ° C with a water bath.
- 1- (1-Chloro-ethyl) -4-isobutyl-benzene (6, 1.97 g, 10.0 mmol) was added dropwise and the Reaction mixture stirred for 2 h at room temperature.
- the titration of the zinc reagent 7 against iodine gave a concentration of 0.33 M (7.2 mmol, 72%).
- a Schlenk tube was heated in a high vacuum and filled with pre-dried via calcium chloride C0 2 gas.
- 1- (4'-Isobutylphenyl) ethylzinc chloride-magnesium chloride-lithium chloride (7.6ml, 0.32M in THF, 1.8mmol) was added and C0 2 gas was bubbled through the solution for 5 min.
- the reaction mixture was stirred for 12 h at 25 ° C and then heated to 50 ° C for 12 h.
- Diethyl ether (20ml) was added and the organic phase extracted with 2M NaOH (3x20ml).
- the combined aqueous phases were acidified with 2 M HCl (pH ⁇ 5) and extracted with diethyl ether (3 ⁇ 20 ml).
- the reaction according to the invention with the electrophile C0 2 was carried out starting from monobenzylic zinc reagents of the composition RZnCl-MgCl 2 -LiCl (prepared according to Metzger, 2008) and bisbenzylic zinc reagents in a comparative experiment.
- 4-fluorobenzylzinc chloride-magnesium chloride-lithium chloride with CO 2 after 12 h at 50 ° C (4-fluoro-phenyl) -acetic acid (2), it could be isolated in 61% yield (see Scheme 7 below).
- bis (2-fluorobenzylzinc) magnesium chloride-lithium chloride (3) could (2-fluoro-phenyl) -acetic acid (4) after 6 h at room temperature in 100% yield isolated.
- the comparative experiment demonstrates that bisbenzylic zinc reagents of the present invention the composition R 2 Zn-2 2MgCl -2LiCl a higher reactivity toward C0 2 having as the primary benzylic zinc reagent composition RZnCl-MgCl 2 -LiCl.
- the diaryl zinc reagent 6a was obtained by reaction of 4-bromoanisole (1.0 equiv.) With Mg (2.5 equiv.), LiCl (0.75 equiv.), And ZnCl 2 (0.55 equiv.) In THF at 25 ° C over 2 h.
- the corresponding diaryl zinc reagent 6a containing MgX 2 (X: Cl, Br; 2.0 equiv) reacts with ketone 2b within 2 h at 25 ° C and both Ar groups are transferred to the ketone (Equation 2, Scheme 8) ).
- Bisarylic zinc compounds of type 6 Ar 2 Zn-2MgX 2 -2LiCl, 0.6 equiv.
- both Ar groups are transferred during the carbonyl addition reaction.
- the addition of i? Z ' s- (4-methoxyphenyl) zinc-2MgX 2 -LiCl (6a) to aliphatic ketones such as dicyclopropyl ketone (2h) or cyclopentanone (2i) occur within 2 h and 12 h respectively and lead to the Alcohols 3h-i in 84-87% yield (entries 2-3).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
L'invention concerne un procédé de production de composés organiques présentant au moins un groupe fonctionnel, notamment des acides carboxyliques, alcools, esters, amides, cétones, aldéhydes ou amines, ainsi que des composés destinés à leur production. L'invention porte également sur des utilisations et sur la production de tels composés.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102010003015.5 | 2010-03-18 | ||
DE102010003015A DE102010003015A1 (de) | 2010-03-18 | 2010-03-18 | Carbonylierung von organischen Zinkverbindungen |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011113925A2 true WO2011113925A2 (fr) | 2011-09-22 |
WO2011113925A3 WO2011113925A3 (fr) | 2011-12-01 |
Family
ID=44170253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2011/054104 WO2011113925A2 (fr) | 2010-03-18 | 2011-03-18 | Carbonylation de composés organiques de zinc |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE102010003015A1 (fr) |
WO (1) | WO2011113925A2 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2746259A1 (fr) | 2012-12-21 | 2014-06-25 | Basf Se | Composés de [1,2,4]triazole et d'imidazole substitués |
EP2746260A1 (fr) | 2012-12-21 | 2014-06-25 | Basf Se | Composés de [1,2,4]triazole et d'imidazole substitués |
CN106518655A (zh) * | 2016-09-08 | 2017-03-22 | 山东理工大学 | 一种通过添加晶形控制剂自水溶液中制备片状布洛芬晶体的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4981995A (en) | 1987-03-20 | 1991-01-01 | Varadaraj Elango | Method for producing ibuprofen |
US5068448A (en) | 1989-12-04 | 1991-11-26 | Hoechst Celanese Corporation | Process for the production of 4'-isobutylacetophenone |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102007022490A1 (de) | 2007-05-14 | 2008-11-20 | Ludwig-Maximilians-Universität | Bisamid-Zinkbasen |
-
2010
- 2010-03-18 DE DE102010003015A patent/DE102010003015A1/de not_active Ceased
-
2011
- 2011-03-18 WO PCT/EP2011/054104 patent/WO2011113925A2/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4981995A (en) | 1987-03-20 | 1991-01-01 | Varadaraj Elango | Method for producing ibuprofen |
US5068448A (en) | 1989-12-04 | 1991-11-26 | Hoechst Celanese Corporation | Process for the production of 4'-isobutylacetophenone |
Non-Patent Citations (8)
Title |
---|
A. A-RAMINI; M. C. CESTA; S. CONIGLIO; C. BIMANI; S. COLAGIOIA; V. D'ELIA; M. ALLEGRETTI, J. ORG. CHEM., vol. 68, 2003, pages 7911 |
A. KRASOVSKIY; F. KOPP; P. KNOCHEL, ANGEW. CHEM. INT. ED., vol. 45, 2006, pages 497 - 500 |
A. KRASOVSKIY; V. MALAKHOV; A. GAVRYUSHIN; P. KNOCHEL, ANGEW. CHEM. INT. ED., vol. 45, 2006, pages 6040 |
A. METZGER; F. PILLER; P. KNOCHEL, CHEM COMM, 2008, pages 5824 |
C. S. YEUNG; V. M. DONG, J. AM. CHEM. SOC., vol. 130, 2008, pages 7826 |
F. M. PILLER; P. APPUKKUTTAN; A. GAVRYUSHIN; M. HELM; P. KNOCHEL, ANGEW. CHEM. INT. ED., vol. 47, 2008, pages 6802 |
H. OCHIAI; M. JANG; K. HIRANO; H. YORIMITSU; K. OSHIMA, ORG. LETT., vol. 10, 2008, pages 2681 |
K. KOBAYASHI; Y. KONDO, ORG. LETT., vol. 11, 2009, pages 2035 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2746259A1 (fr) | 2012-12-21 | 2014-06-25 | Basf Se | Composés de [1,2,4]triazole et d'imidazole substitués |
EP2746260A1 (fr) | 2012-12-21 | 2014-06-25 | Basf Se | Composés de [1,2,4]triazole et d'imidazole substitués |
CN106518655A (zh) * | 2016-09-08 | 2017-03-22 | 山东理工大学 | 一种通过添加晶形控制剂自水溶液中制备片状布洛芬晶体的方法 |
CN106518655B (zh) * | 2016-09-08 | 2019-01-04 | 山东理工大学 | 一种通过添加晶形控制剂自水溶液中制备片状布洛芬晶体的方法 |
Also Published As
Publication number | Publication date |
---|---|
WO2011113925A3 (fr) | 2011-12-01 |
DE102010003015A1 (de) | 2011-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60132771T2 (de) | Verfahren zur herstellung von cyclopropylcarbonsäureestern und deren derivaten | |
DE69808093T2 (de) | Verfahren zur herstellung von 2-substituierten 1-(tetrazol-5-yl)benzenverbindungen durch ortho-metallierung | |
EP1436300B1 (fr) | Procede de production, via des organometalliques, de produits intermediaires organiques | |
EP0579797B1 (fr) | Ligands diphosphiniques | |
DE10240262A1 (de) | Verfahren zur metallorganischen Herstellung organischer Zwischenprodukte über Aryllithium-Basen | |
DE602006000226T2 (de) | Verfahren zur Herstellung von Adapalene | |
EP1988095B1 (fr) | Procédé de fabrication d'acides de bore aminoaryle ou hétéroaryl et leurs dérivés | |
EP0606065A1 (fr) | Procédé pour la préparation de dérivés de biphényle | |
WO2011113925A2 (fr) | Carbonylation de composés organiques de zinc | |
EP3381895B1 (fr) | Procédé de production d'un thioester d'acide carboxylique | |
DE10111262A1 (de) | Verfahren zur Herstellung von Vinyl- Aryl- und Heteroarylessigsäuren und ihrer Devivate | |
WO2003033505A1 (fr) | Procede de production organometallique de produits intermediaires organiques par l'intermediaire de bases lithium amide | |
DD202427A5 (de) | Verfahren zur herstellung von alpha-halogenalkylamiden | |
DE69903498T2 (de) | Verfahren zur Herstellung von 13-cis-Retinsäure | |
JP2002322122A (ja) | カルボン酸エステルの製造方法、ならびにその“オニウム”塩および塩混合物 | |
EP3688000B1 (fr) | Réactifs d'échange halogène/magnésium et thiolate/magnésium solubles dans les hydrocarbures | |
EP1955991A2 (fr) | Préparation de composés organique portant un groupe trifluorométhyle sur un carbone quaternaire | |
Niedermann | Direct trifluoromethylation of organonitrogen compounds with hypervalent iodine reagents | |
DE19743985A1 (de) | Verwendung von Tris(trifluoromethylsulfonyl)methan und dessen Alkali- und Erdalkalimetallsalzen als Katalysatoren bei C-C verknüpfenden Synthesen und das neue Mg-Salz von Tris(trifluoromethylsulfonyl)methan | |
DE102004047794A1 (de) | Verfahren zur Hydrierung von a,ß-ungesättigten Carbonylverbindungen | |
JPS5838261A (ja) | 新規な1,3−二置換イミダゾ−ル誘導体及びその製造方法 | |
EP0391212A2 (fr) | Procédé de préparation de composés de stilbène bifonctionnels ayant la configuration Z, composés de stilbène ayant cette configuration ainsi que leur utilisation pour la préparation de polymères | |
DE102006050717A1 (de) | Verfahren zur Herstellung funktionalisierter Fünfringheterocyclen und deren Verwendung | |
DE19632643C1 (de) | Katalysierte Kopplung von Arylmagnesiumhalogeniden und Bromarylcarbonsäureverbindungen zur Herstellung von Biphenylcarbonsäuren | |
DE69711397T2 (de) | Herstellung von einem hydrazon-beta-ketoester durch reaktion mit einem diazoester |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11709122 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11709122 Country of ref document: EP Kind code of ref document: A2 |